… noninvasive biomarkers (Cho et al., 2017a). Notably, the latest research shows that the
number of circulating EVs and their sphingolipid cargoes can be used very powerful biomarker to …

… by cargo analysis could represent a good strategy for biomarker discovery in NAFLD. …
Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding …

… EVs may potentially improve biomarker discovery and … that new developments around the
selective isolation of liver-… specificity to NAFLD in the context of other chronic liver diseases. …

… Exploring the precise mechanism of EVs in NAFLD will help us identify new biomarkers. …
extracellular vesicles and non-alcoholic fatty liver disease: new players in the gut-liver axis? Am …

… concerning the role of EVs as new structures mediating autocrine and paracrine intercellular
communication in both ALD and NAFLD, as well as their potential use as biomarkers of …

… Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent chronic liver disease in most
… pathogenesis of the disease which is also a promising candidate for biomarkers and therapy …

… non-alcoholic fatty liver disease (NAFLD) and non-alcoholic … , biomarker research involves
tools and technologies, which can help in understanding the various phases of a disease, …

… injury models suggests that EV microRNA may serve as biomarkers for liver disease. … an
attractive target for biomarker discovery, with the challenge of establishing disease-specific EV …

… Non-alcoholic fatty liver disease (NAFLD), the most common chronic liver disease, affects
about 25 percent of the world’s population and causes a heavy economic burden (Younossi et …

… , alcoholic and non-alcoholic fatty liver disease, hepatic malignancies and drug-induced …
Though EVs are an emerging frontier in liver research, it remains an uphill battle to successfully …